左心室心肌致密化不全患者的临床风险预测
本研究为回顾性纵向多中心队列研究,纳入585例符合超声心动图或心脏磁共振LVNC标准的患者,中位随访5.1年,38%发生MACE。LVEF是与MACE独立相关的主要变量,LVEF>35%患者中LGE与心衰和室性心律失常相关;建立的Cox预测模型在衍生队列和外部验证队列C-index均为0.72。
要点
- LVEF是与MACE独立相关的主要变量(P<0.05)。
- LVEF>35%患者中LGE与心衰和室性心律失常相关(P<0.05)。
- 无心电图异常、LVEF≥50%、无LGE且家族筛查阴性者随访无MACE。
核心结论
- LVNC与心衰和室性心律失常风险增加相关。
- LVEF是与MACE关联最强的变量,但LGE在无严重收缩功能障碍患者中 confer 额外风险。
- 开发并验证了风险预测模型以指导管理。
研究设计与样本
- 回顾性纵向多中心队列研究,纳入585例符合超声心动图或心脏磁共振LVNC标准的连续患者。
- 患者年龄45±20岁,男性57%,LVEF 48%±17%,18%存在LGE。
- 中位随访5.1年。
主要发现
- 随访期间223例(38%)发生MACE:心衰110例(19%)、室性心律失常87例(15%)、系统性栓塞18例(3%)、死亡34例(6%)。
- LVEF是与MACE独立相关的主要变量(P<0.05)。
- LVEF>35%患者中LGE与心衰和室性心律失常相关(P<0.05)。
关键数值与推荐
- 预测模型由年龄、性别、心电图、心血管危险因素、LVEF和家族聚集性组成。
- 衍生队列C-index为0.72(95%CI:0.67-0.75),外部验证队列C-index为0.72(95%CI:0.71-0.73)。
- 无心电图异常、LVEF≥50%、无LGE且家族筛查阴性者随访无MACE。
临床怎么用
- LVEF应作为LVNC患者风险分层的主要指标。
- LVEF>35%患者应评估LGE以识别心衰和室性心律失常额外风险。
- 无心电图异常、LVEF≥50%、无LGE且家族筛查阴性者可能无需密集随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Left ventricular noncompaction (LVNC) is a heterogeneous entity with uncertain prognosis. OBJECTIVES: This study sought to develop and validate a prediction model of major adverse cardiovascular events (MACE) and to identify LVNC cases without events during long-term follow-up. METHODS: This is a retrospective longitudinal multicenter cohort study of consecutive patients fulfilling LVNC criteria by echocardiography or cardiovascular magnetic resonance. MACE were defined as heart failure (HF), ventricular arrhythmias (VAs), systemic embolisms, or all-cause mortality. RESULTS: A total of 585 patients were included (45 ± 20 years of age, 57% male). LV ejection fraction (LVEF) was 48% ± 17%, and 18% presented late gadolinium enhancement (LGE). After a median follow-up of 5.1 years, MACE occurred in 223 (38%) patients: HF in 110 (19%), VAs in 87 (15%), systemic embolisms in 18 (3%), and 34 (6%) died. LVEF was the main variable independently associated with MACE (P < 0.05). LGE was associated with HF and VAs in patients with LVEF >35% (P < 0.05). A prediction model of MACE was developed using Cox regression, composed by age, sex, electrocardiography, cardiovascular risk factors, LVEF, and family aggregation. C-index was 0.72 (95% confidence interval: 0.67-0.75) in the derivation cohort and 0.72 (95% confidence interval: 0.71-0.73) in an external validation cohort. Patients with no electrocardiogram abnormalities, LVEF ≥50%, no LGE, and negative family screening presented no MACE at follow-up. CONCLUSIONS: LVNC is associated with an increased risk of heart failure and ventricular arrhythmias. LVEF is the variable most strongly associated with MACE; however, LGE confers additional risk in patients without severe systolic dysfunction. A risk prediction model is developed and validated to guide management.
引用
- Casas G, Limeres J, Oristrell G, et al. Clinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction. J Am Coll Cardiol. 2021. PMID: 34384546. doi:10.1016/j.jacc.2021.06.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。